MedTrace Logo

Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

NCT00154024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-09-28

No results posted yet for this study

Summary

Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.

Conditions

  • Healthy Subjects

Interventions

DRUG

atorvastatin

DRUG

irbesartan

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Wilhelm Kirch, MD · Institute of Clinical Pharmacology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Completion
2006-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00154024 on ClinicalTrials.gov